Recovery of stroke - longitudinal assessment with neuroimaging (rose lawn) - program director/principal investigator (last, first, middle): WOO, daniel; anderson, christopher 3. Project…

Ended Project Grant Awarded Last action

Award ID
R01NS120493
Recipient
Awarding agency
Obligated
$2,199,898

Award facts

Completion date
Place of performance
Ohio, USA

Award details come from USAspending.gov.

Description

Recovery of stroke - longitudinal assessment with neuroimaging (rose lawn) - program director/principal investigator (last, first, middle): WOO, daniel; anderson, christopher 3. Project summary/abstract we have recently completed analyses which identifies a population of patients that have a markedly increased risk of developing dementia/progressive cognitive impairment. Intracerebral hemorrhage patients had been reported to have a 42% risk of progressive cognitive impairment roughly 3 and a half years after their stroke and we have found a 39% risk in an independent population of patients. This extraordinarily high rate among survivors of ICH without a prior history of dementia yields multiple different hypotheses. First, IT may be that the causes of ICH itself are also risk factors for dementia. If so, then those that develop dementia should demonstrate worsening markers of these causes such as cerebral small vessel disease and cerebral amyloid angiopathy. However, another prominent hypothesis in the field is that the hemorrhage itself is markedly inflammatory. If this inflammatory response were to trigger a progressive cognitive decline, then these cases should demonstrate differential inflammatory gene expression changes. The recovery of stroke (NS100417) study has recruited 163 cases out of a planned 500 total cases of ICH including 3T MRI, baseline and 3 month samples for DNA, RNA-sequencing and detailed baseline, 3 and 6 month motor, cognitive, behavioral and functional examinations. The current proposal seeks to RE-enroll 250 cases of the planned 500 for 12 to 24 month follow-up neuroimaging, RNA sampling and repeated examination measures to address the following aims: 1) determine if progressive cognitive impairment correlates with an increase in markers of cerebral small vessel disease and cerebral amyloid angiopathy; 2) determine if inflammation as measured by RNA-sequencing markers of inflammation correlates with progressive cognitive impairment and 3) identify novel neuroimaging markers associated with progressive cognitive decline. If successful, we will provide the largest longitudinal multiple assessment evaluation of ICH and answer the major hypotheses on the development of dementia among survivors of ICH. PHS 398/2590 (REV. 06/09) page continuation format page

Transactions

Action Obligated Date
Amendment -$22,390
Amendment -$158,450
Amendment -$129,877
Amendment -$594,059
Amendment $0
Amendment $61,645
Amendment $12,988
Amendment $554,804
Amendment $116,889
Amendment $75,199
Amendment $130,191
Amendment $546,595
Amendment $76,211
Amendment $125,319
Amendment $560,568
Amendment $2,834
Amendment $139,299
Original award $702,132
Show all 18

Subawards

Subrecipient Amount Awarded
University Of Illinois Amend #6 $5,168
Duke University $5,168
Duke University Amend #5 $3,978
University Of Illinois $4,381
Wake Forest University Health Sciences Amend #3 $92,903
Childrens Hospital Medical Center $12,948
University Of Maryland, Baltimore $5,168
University Of Maryland, Baltimore Amend #6 $5,168
The Trustees Of Columbia University In The City Of New York Amend #4 FP $5,168
The Trustees Of Columbia University In The City Of New York Amend #3 CR $8,666
University Of Maryland, Baltimore Amend #5 $3,867
Duke University Amend #4 $4,107
Duke University Amend #3 $5,168
Baptist Healthcare System Inc. Amend #1 $5,328
University Of Illinois Amend #3 $5,328
Wake Forest University Health Sciences Amend #2 $92,903
The Trustees Of Columbia University In The City Of New York Amend #3 $5,328
The Trustees Of Columbia University In The City Of New York Amend #2 $8,666
The Methodist Hospital $5,328
Childrens Hospital Medical Center $12,948
University Of Maryland, Baltimore Amend #3 $3,867
University Of Maryland, Baltimore Amend #4 $5,328
Baptist Healthcare System Inc. Recovery of StrokE - Longitudinal Assessment With Neuroimaging (ROSE LAWN) (Baptist Health System SOW) $5,168
Duke University Amend #2 $5,168
Show all 24

Quick answers

Who received award R01NS120493?

R01NS120493 was awarded to Cincinnati Univ Of by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on December 4, 2020.

How much is award R01NS120493 worth?

$2,199,898 has been obligated on R01NS120493.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award